Gabriel Liberatore

Gabriel Liberatore has extensive experience in the medical and biopharmaceutical sectors, currently serving as a Non Executive Director at OncoSil Medical and as a Strategic Advisor at GlyTherix Ltd. As a Committee Member for AusBiotech, Gabriel contributes to the biotechnology community. Previous leadership roles include Group Chief Operating Officer at Telix Pharmaceuticals Limited and General Manager of Research & Development at both Pact Group Holdings Ltd and Swisse Wellness. An academic background includes a PhD in Medicine/Neuroscience, an MBA in Business Strategy, and the completion of the Company Directors Course at the Australian Institute of Company Directors. Gabriel's research experience includes a role as a Research Fellow at the National Stroke Research Institute.